Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.10 (
IKK
)
4,900
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TAK1, a member of the MAP3K family, plays an essential role in activation of JNK/p38 MAPKs and
IKK
in the IL-1beta and TNFalpha signaling pathway. Upon stimulation, TAK1 is rapidly and transiently activated. While the activation mechanism of TAK1 in these signaling pathways is well characterized, how its activity is terminated still remains unclear. To identify the molecule(s) involved in TAK1 regulation, we performed tandem affinity purification (TAP) in HeLa cells stably expressing TAP-tagged TAK1.
FBXW5
, an F-box family protein, was identified as a previously unknown component of the IL-1beta-induced TAK1 complex.
FBXW5
associated with endogenous TAK1 in an IL-1beta-dependent manner. Overexpression of
FBXW5
inhibited IL-1beta-induced activation of JNK/p38 MAPKs and NF-kappaB as well as phosphorylation of TAK1 on Thr187. Conversely, knockdown of
FBXW5
resulted in the prolonged activation of TAK1 upon IL-1beta stimulation. These results suggest that
FBXW5
negatively regulates TAK1 in the IL-1beta signaling pathway.
...
PMID:An F-box protein, FBXW5, negatively regulates TAK1 MAP3K in the IL-1beta signaling pathway. 1923 15